The steroid in question is dehydroepiandrosterone, or DHEA, which is secreted by the adrenal gland and circulates in blood mainly in a sulfated form, DHEA-S. In other tissues, DHEA-S is converted into the sex hormones testosterone and estrogen.
Previous, smaller studies found an association between low DHEA-S levels and heart and blood-vessel, or cardiovascular, disease, although their results were inconclusive. At this time, while we know that DHEA production decreases with age, the exact health effects of its decline are unclear.
In this large-scale study, investigators study found that elderly men with the lowest DHEA-S blood levels were significantly more likely than those with higher concentrations to develop cardiovascular-disease events within five years. The increased risk persisted even after controlling for other influences, indicating that low DHEA-S levels are independently associated with a greater risk of disease.
"Our findings may be the result of DHEA-S being protective, or that lower DHEA-S level is a marker for poor general health," said study lead author Åsa Tivesten, M.D., Ph.D., associate professor at the University of Gothenburg, Sweden. "More research is needed to understand underlying mechanisms and to evaluate the potential benefits of hormone replacement."Investigators used an advanced laboratory technique to isolate, identify, and measure DHEA-S levels in the blood. During the five-year follow-up, they used nationwide medical registries to document 485 cases of cardiovascular disease among the study participants.
According to Tivesten, it is important to note that this study's findings only indicate that low DHEA-S levels may be related to a greater risk of cardiovascular disease. "We cannot say that DHEA-S is protective because we have only studied an association," she said.
Aaron Lohr | EurekAlert!
Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg
An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...
Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.
Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
03.06.2020 | Medical Engineering
03.06.2020 | Physics and Astronomy
03.06.2020 | Physics and Astronomy